Fractyl Health (GUTS) Other Accumulated Expenses (2023 - 2026)
Fractyl Health (GUTS) reported Other Accumulated Expenses of $596000.0 for Q1 2026, down 92.54% year-on-year from $8.0 million in Q1 2025, and down 37.98% quarter-over-quarter from $961000.0 in Q4 2025.
Fractyl Health (GUTS) has 4 years of Other Accumulated Expenses data on file, last reported at $596000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses fell 92.54% year-over-year to $596000.0; the trailing twelve-month figure through Mar 2026 stood at $596000.0 (down 92.54% YoY), and the FY2025 full-year result was $961000.0, up 15.64% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $596000.0, down from $961000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $8.0 million in Q1 2025 and bottomed at $2000.0 in Q4 2023.
- A 4-year average of $1.2 million and a median of $506000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses soared 41450.0% in 2024 and tumbled 92.54% in 2026, its largest moves.
- Tracing GUTS's Other Accumulated Expenses over 4 years: stood at $2000.0 in 2023, then soared by 41450.0% to $831000.0 in 2024, then rose by 15.64% to $961000.0 in 2025, then tumbled by 37.98% to $596000.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $596000.0, $961000.0, and $507000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 596,000.00 |
| Dec 31, 2025 | 961,000.00 |
| Sep 30, 2025 | 507,000.00 |
| Jun 30, 2025 | 505,000.00 |
| Mar 31, 2025 | 7.99 Mn |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 445,000.00 |
| Jun 30, 2024 | 427,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Dec 31, 2023 | 2,000.00 |